Navigation Links
Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
Date:6/30/2010

Therapure Biopharma Inc. today announced an agreement under which Therapure will provide development services for Diamedica Incorporated, a biopharmaceutical company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide cell line development and protein production services to support clinical development for one of Diamedica’s products, a protein which may be used for the treatment of diabetes and neurological disorders. The companies are also negotiating contracts for on-going GMP manufacturing services. Financial terms were not disclosed.

Toronto, ON (Vocus) June 30, 2010 -- Therapure Biopharma Inc. today announced an agreement under which Therapure will provide development services for Diamedica Incorporated, a biopharmaceutical company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide cell line development and protein production services to support clinical development for one of Diamedica’s products, a protein which may be used for the treatment of diabetes and neurological disorders. The companies are also negotiating contracts for on-going GMP manufacturing services. Financial terms were not disclosed.

DiaMedica Inc. (DiaMedica) is a Canada-based biopharmaceutical company focused on developing treatments for diseases with significant unmet need including diabetes and neurological diseases. The Company has been selected as one of Canada’s Top 10™ life science companies in 2007/2008 and 2008/2009 by the Ottawa Centre for Research and Innovation (OCRI) and has several compounds in various stages of development.

“We are proud to have been chosen by Diamedica as its partner to provide cell line development and protein production services” said Thomas Wellner, President and CEO of Therapure. “Therapure has performed similar services for a number of clients and has demonstrated market leading expertise,” continued Mr. Wellner.

'Diamedica was seeking a cell line developer with the scientific expertise to handle this specialty product,' said Rick Pauls, CEO of Diamedica Inc. 'This project is important to DiaMedica’s future success and we are confident in Therapure’s ability to meet our needs'.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

# # #

Read the full story at http://www.prweb.com/releases/biopharma/manufacturing/prweb4204774.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
3. Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
4. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
5. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
6. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
7. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
(Date:5/25/2016)... ... 2016 , ... Founder of the Fitzmaurice Hand Institute in ... of the hand by the National Board of Physicians and Surgeons, as of ... in his pursuit of providing the most comprehensive, effective treatment for his patients, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Scientists at the University of Athens say ... mesothelioma may be hampering the research that could lead to one good one. Surviving ... read it now. , The team evaluated 98 mesothelioma patients who ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Lady had been ... tore her cruciate ligament in her left knee. Lady’s owner Hannah sought the help ... Florida board-certified veterinary surgeon, to repair her cruciate ligament and help with the pain ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic ... into engines of wound healing and tissue regeneration. , The novel method, developed ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):